POLYVALENT IODINE AND DERIVED CHEMISTRY
多价碘及其衍生化学
基本信息
- 批准号:6343004
- 负责人:
- 金额:$ 30.32万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-01-01 至 2002-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Acetylenes as well as Esters of all types (carboxylate, phosphate,
sulfonate) are among the most ubiquitous, important and valuable
functionalities and compounds in organic chemistry. Both play key roles
in mechanistic, synthetic and bioorganic chemistry. Recently, we have
discovered and prepared novel types of functionalized acetylenes,
alkynyliodonium salts, as well as the hitherto unknown alkynyl esters.
We shall capitalize and build upon this exciting development by
elaborating the chemistry, as well as the medicinal and biochemistry of
our new alkynyliodonium species and alkynyl esters. Specifically, we
shall investigate: a) electrocyclic cycloadditions of both
alkynyliodonium species and alkynyl esters; b) alkynylations and
electrophilic acetylene chemistry, c) alkynyl amino acids via RC (triple
bond) CIPhOTf; d) siloxyacetylene and ynolate chemistry; e) conjugated
enyne formation via coupling of RC(triple bond)CIPhOTf; f) P-ylides; g)
vinyliodonium species.
We shall continue to examine the medicinal and biochemical,properties and
significance of these compounds. Alkynyliodonium and phosphonium salts
will be evaluated as potential new antitumor agents via "alkynylation" of
biological nucleophiles. Data already in hand indicate that some members
of this family are active against murine leukemia cells (L1210) and
human-T-lymphoblast cells (Molt-4F) as well as the human-T-lymphocyte
(MT-4) cells. Alkynyl carboxylates and phosphates will be examined as
mechanism based protease and phosphatase inhibitors ("suicide
substrates"). Preliminary results show that CH3C(triple bond)COC(O)Ar
are potent inhibitors of serine based proteases. Similarly, n-BuC(triple
bond)COP(O)(OEt)2 and related alkynyl phosphate esters are potent
inhibitors of a bacterial triester phosphatase.
This program of fundamental research on two relatively new types-and
classes of compounds, namely alkynyliodonium salts and alkynyl esters,
has major implications for synthetic, physical-organic, medicinal, as
well as bioorganic chemistry.
乙炔以及各种类型的酯类(羧酸酯、磷酸酯、
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Peter J Stang其他文献
Metallacycles and Metallacages with Imidazole-based Ligands and their in Vitro Anticancer Activity
咪唑基配体的金属环和金属环及其体外抗癌活性
- DOI:
- 发表时间:
2019 - 期刊:
- 影响因子:0
- 作者:
Yibo Zhao;Liqian Zhang;Xu Li;Yanhui Shi;Ruru Ding;Mengting Teng;Peng Zhang;Changsheng Cao;Peter J Stang;Yanhui Shi - 通讯作者:
Yanhui Shi
Peter J Stang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Peter J Stang', 18)}}的其他基金
相似海外基金
The analysis of proteinuria caused by antineoplastics and the preventative effects with antihypertensive medications using the Japanese medical database
利用日本医学数据库分析抗肿瘤药物引起的蛋白尿及抗高血压药物的预防效果
- 批准号:
21K17258 - 财政年份:2021
- 资助金额:
$ 30.32万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Expediting Drug Development by Profiling Novel Antineoplastics by Mass Spectrometry-based Biomarker Profiling
通过基于质谱的生物标志物分析来分析新型抗肿瘤药物,加速药物开发
- 批准号:
499958-2016 - 财政年份:2016
- 资助金额:
$ 30.32万 - 项目类别:
Engage Grants Program
Combinatorial Peptidomimetics as Antineoplastics
作为抗肿瘤药的组合肽模拟物
- 批准号:
6623455 - 财政年份:2002
- 资助金额:
$ 30.32万 - 项目类别:
Combinatorial Peptidomimetics as Antineoplastics
作为抗肿瘤药的组合肽模拟物
- 批准号:
6465958 - 财政年份:2002
- 资助金额:
$ 30.32万 - 项目类别:
Novel Nanoparticle Delivery System for Antineoplastics
新型抗肿瘤纳米颗粒输送系统
- 批准号:
6483914 - 财政年份:2002
- 资助金额:
$ 30.32万 - 项目类别:
GLYCOLIPIDS AND CYTOTOXIC RESPONSE TO ANTINEOPLASTICS
糖脂和抗肿瘤药物的细胞毒性反应
- 批准号:
6124630 - 财政年份:1998
- 资助金额:
$ 30.32万 - 项目类别:
GLYCOLIPIDS AND CYTOTOXIC RESPONSE TO ANTINEOPLASTICS
糖脂和抗肿瘤药物的细胞毒性反应
- 批准号:
6329037 - 财政年份:1998
- 资助金额:
$ 30.32万 - 项目类别:
GLYCOLIPIDS AND CYTOTOXIC RESPONSE TO ANTINEOPLASTICS
糖脂和抗肿瘤药物的细胞毒性反应
- 批准号:
2747737 - 财政年份:1998
- 资助金额:
$ 30.32万 - 项目类别:
POLYMORPHIC METABOLISM OF ANTINEOPLASTICS IN CHILDREN
儿童抗肿瘤药物的多态性代谢
- 批准号:
3459680 - 财政年份:1990
- 资助金额:
$ 30.32万 - 项目类别:
POLYMORPHIC METABOLISM OF ANTINEOPLASTICS IN CHILDREN
儿童抗肿瘤药物的多态性代谢
- 批准号:
3459678 - 财政年份:1990
- 资助金额:
$ 30.32万 - 项目类别: